VC  Fountain Healthcare Partners

http://www.fh-partners.com





     Office Locations:

Two Docklands Central, Level 4
Guild Street, IFSC
Dublin, D01 K2C5
Ireland
Phone: 353-1-5225100

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Fountain Healthcare Partners is a spin-out group from Elan Corporation's (NYSE:ELN) New York-based corporate venture capital group. While at Elan, the team invested in over 25 life science companies, developing the next generation of products and technologies to address unmet medical needs. Fountain Healthcare Partners I fund is the largest dedicated life science venture capital fund in Ireland. The fund had a first close at 75M Euro in April 2008. Fountain's main office is in Dublin, Ireland, with a second office in New York. Specific areas of interest to Fountain are: specialty pharma, medical devices, biotechnology and diagnostics. The firm will deploy the majority of its capital in Europe with a strong focus on Ireland. Fountain will invest in private companies at all stages of development with an emphasis on companies with experienced management teams seeking capital to fund product development activities. Fountain aims to build a portfolio of 10 to 15 life science companies, allocating between 7M and 10M Euro per company over the life of the investment.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Aidan King MBA, CFA Co-Founder and Managing Partner
    Dr. Ena Prosser Ph. D Partner
    Dr. Manus Rogan Ph. D., MBA Co-Founder and Managing Partner
    Justin Lynch MBA Partner and CFO

     

    Portfolio companies include:


      Amarin
        web link


      Cappella
        web link


      Chrono Therapeutics
        web link


      Civitas Therapeutics
        web link


      Genable Technologies
        web link


      Inflazome
        web link


      Innocoll
        web link


      KaNDy Therapeutics
        web link


      Mainstay Medical
        web link


      NeRRe Therapeutics
        web link


      Neuravi
        web link


      Neurent Medical


      Neuromod
        web link


      Opsona Therapeutics
        web link


      Palyon Medical
        web link


      Trino Therapeutics
        web link


      Velicept Therapeutics
        web link


      Vivasure Medical
        web link


     

    Recent News: